Data Presentations Featured News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Data Presentations Featured. Real-time updates on events, politics, business and more.

Biogen Inc.: New Data at ECTRIMS 2022 Highlight Biogen's Commitment to Advancing Individualized Disease Management for People Living with MS

October 26, 2022

Final safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tolerability for VUMERITY (diroximel fumarate) consistent with previous

Nordrhein Westfalen United Kingdom Maha Radhakrishnan Charles Weissmann Walter Gilbert Heinz Schaller

Source: finanznachrichten.de

Biogen Inc.: New MS PATHS Data at ECTRIMS 2021 Confirm Biogen's Disease-Modifying Therapies Do Not Reduce Antibody Response to COVID-19 Vaccines in People with Multiple Sclerosis

October 13, 2021

MS PATHS data indicate that 100 percent of people with MS treated with natalizumab, interferons or fumarates achieved an antibody response following COVID-19 vaccinationData from this analysis also suggest

United Kingdom United States Jeffrey Cohen Maha Radhakrishnan Walter Gilbert Charles Weissmann

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Data Presentations Featured News Today

Biogen Inc.: New Data at ECTRIMS 2022 Highlight Biogen's Commitment to Advancing Individualized Disease Management for People Living with MS

Biogen Inc.: New MS PATHS Data at ECTRIMS 2021 Confirm Biogen's Disease-Modifying Therapies Do Not Reduce Antibody Response to COVID-19 Vaccines in People with Multiple Sclerosis

Explore More Categories